Deep Tech Startups

Leia Inc. develops the Immersity platform, combining AI software with switchable-display hardware that lets devices such as phones, tablets, laptops, and monitors switch between standard content and immersive 3D experiences. The company builds display technology and spatial intelligence products for consumer devices.

3 investors

Leon develops nanoparticle-based drug delivery systems for therapeutic applications in healthcare. The company leverages nanotechnology to improve drug efficacy and patient outcomes.

3 investors

Letta is an AI research lab building self-improving digital agents that use memory-native reinforcement learning and programmatic context management to learn continuously from experience over time.

3 investors

Level Nine develops nanozyme technology that combines enzymes with nanotechnology to create catalysts for green chemistry and the green chemicals industry.

3 investors

LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.

3 investors

Lifordi Immunotherapeutics develops treatments for immunology and rare diseases through discovery, clinical development, and commercialization. The company serves patients with immunological disorders and rare genetic conditions.

3 investors

LIFT Aircraft develops a new type of personal, electric vertical-takeoff aircraft and operates an experiential entertainment business that lets everyday people fly. It aims to make personal, vertical flight accessible beyond traditional pilots.

3 investors

Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale. The platform serves researchers and therapeutics developers studying functional biology for applications in antibody discovery, cellular therapies, and immunotherapy development.

3 investors

LightSpeed Photonics builds modular optoelectronic processors and optical interconnects aimed at bandwidth-intensive computing workloads. Its LightCompute modules are intended for data center and edge deployments where high throughput and low latency are required for real-time processing.

3 investors

Lime Microsystems designs field-programmable RF transceivers and software-defined radio silicon for wireless broadband infrastructure and adjacent applications. The company serves mobile operators, researchers, and system integrators with FPRF technology and SDR platforms that enable dynamic spectrum adaptation.

3 investors

Limula develops an automated, closed platform for manufacturing personalized cell and gene therapies, aiming to move production from open, manual methods to scalable automated processes. It serves cell therapy developers and manufacturers in the biotech and pharmaceutical industry, and is based in Switzerland.

3 investors

Liquid Instruments develops Moku, a reconfigurable integrated test system for complex research and development applications. The platform serves engineers and scientists who need customizable test configurations for advanced testing scenarios.

3 investors

Lita builds zero-knowledge proof infrastructure, including Valida, a zkVM with compiler tooling that lets developers write zkSTARKs using general-purpose languages like C and Rust, plus an open-source STARK toolkit for arithmetization and polynomial interactive proofs. It targets developers and applications needing verifiable computation and provides integration support from applied cryptography researchers.

3 investors

Litus develops advanced chemistry and nanotechnology solutions to address energy challenges. The company serves the energy and climate sectors with breakthrough technologies originating from university research.

3 investors

LM Studio offers Bionic, a locally-run AI agent designed to work with open models for creativity, work, and coding tasks. The product runs natively on local machines rather than in the cloud.

3 investors

Locus Biosciences develops engineered bacteriophage therapies for treating bacterial infections and conditions in immunology, oncology, and CNS disorders. It uses a technology platform combining robotics, automated biobanking, AI-driven cocktail prediction, and synthetic biology, and operates a cGMP viral vector manufacturing facility for clinical trial material.

3 investors

Logical Intelligence is developing an energy-based AI model aimed at generating verified code for critical systems across industries.

3 investors

Loom Network is a multichain interoperability platform and Delegated Proof of Stake blockchain (Basechain) that lets developers build and host Solidity-based, Ethereum-compatible decentralized applications with fast, gas-free transactions. It serves dapp developers across major chains such as Bitcoin, Ethereum, Binance Chain, and Tron, and also runs CryptoZombies, a code school for learning to build Ethereum dapps.

3 investors

LoadSight is an AI-powered productivity monitoring system that uses 3D LiDAR, night-vision cameras, and on-board edge AI to automatically measure load volumes, convert them to tonnage, and record load-haul-dump cycle times for dump trucks and LHDs. It targets mining operations, delivering verifiable reports and point-cloud data through an edge-served web dashboard that works without network connectivity.

3 investors

LoQus23 Therapeutics is a drug discovery company developing treatments for triplet repeat expansion diseases such as Huntington's disease, focused on preclinical CNS and neuroscience research. Founded in 2019 out of the Dementia Discovery Fund, it operates in the biotech and therapeutics sector.

3 investors

LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction. The company works in the biopharmaceutical field, building a platform based on its proprietary iMIT mitochondria technology.

3 investors

Lucky Robots builds a game engine purpose-built for robotics that generates large volumes of simulation data for training robotic AI, using MuJoCo physics and a Vulkan renderer to transfer learned behaviors from simulation to real robots. It also offers a cloud workspace for hosting robot projects, datasets, models, and simulation runs, serving robotics engineers and researchers.

3 investors

Luminoma is developing the LumAssure, a portable diagnostic-aid that uses Raman spectroscopy to non-invasively assess whether a skin lesion is likely malignant or benign within seconds. The device is intended to help clinicians make more objective skin cancer biopsy decisions and reduce unnecessary biopsies.

3 investors

Lumiode develops wafer-level μLED technology for ultra high-brightness, low-cost micro-displays used in wearable, automotive, and industrial products. It is a subsidiary of PlayNitride Inc. with a team of display and semiconductor specialists in TFT and μLED process development and ASIC and hardware product development.

3 investors